
Sign up to save your podcasts
Or


A spectacular predatory dinosaur fossil was auctioned this week in Paris. It was bought by a private collector at the cost of about 2 million Euros. Academic palaeontologists are not happy about the sale. Anjali Goswami of the Natural History Museum and Steve Brussatte of Edinburgh University air their views to Adam Rutherford on the legal and illegal markets for premium vertebrate fossils.
Who owns the genetic biodiversity of the oceans? One single multinational corporation - the chemicals giant BASF - has registered almost half of all known patents on genetic sequences from marine organisms. This is the headline finding of a survey of marine genetic resource ownership by David Blasiak of the Global Resilience Centre at Stockholm University.
Immunotherapies for cancer have been in the news in the last week. Adam talks to cancer researchers Sophie Papa of Kings College, London and Samra Turaljik of the Royal Marsden Hospital about the principles behind immunotherapy and the different approaches in the clinic and under clinical trials.
Producer: Andrew Luck-Baker
By BBC Radio 44.4
283283 ratings
A spectacular predatory dinosaur fossil was auctioned this week in Paris. It was bought by a private collector at the cost of about 2 million Euros. Academic palaeontologists are not happy about the sale. Anjali Goswami of the Natural History Museum and Steve Brussatte of Edinburgh University air their views to Adam Rutherford on the legal and illegal markets for premium vertebrate fossils.
Who owns the genetic biodiversity of the oceans? One single multinational corporation - the chemicals giant BASF - has registered almost half of all known patents on genetic sequences from marine organisms. This is the headline finding of a survey of marine genetic resource ownership by David Blasiak of the Global Resilience Centre at Stockholm University.
Immunotherapies for cancer have been in the news in the last week. Adam talks to cancer researchers Sophie Papa of Kings College, London and Samra Turaljik of the Royal Marsden Hospital about the principles behind immunotherapy and the different approaches in the clinic and under clinical trials.
Producer: Andrew Luck-Baker

7,708 Listeners

532 Listeners

881 Listeners

1,040 Listeners

283 Listeners

5,541 Listeners

726 Listeners

2,021 Listeners

614 Listeners

94 Listeners

960 Listeners

415 Listeners

88 Listeners

824 Listeners

248 Listeners

354 Listeners

353 Listeners

475 Listeners

372 Listeners

232 Listeners

324 Listeners

3,155 Listeners

110 Listeners

64 Listeners

859 Listeners

1,001 Listeners

500 Listeners

612 Listeners

116 Listeners

279 Listeners

282 Listeners

65 Listeners

82 Listeners

0 Listeners